Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Operating Income (2023 - 2025)

Historic Operating Income for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$2.1 million.

  • Onconetix's Operating Income rose 2179.34% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.7 million, marking a year-over-year increase of 743.08%. This contributed to the annual value of -$56.5 million for FY2024, which is 5676.26% down from last year.
  • Latest data reveals that Onconetix reported Operating Income of -$2.1 million as of Q3 2025, which was up 2179.34% from -$1.9 million recorded in Q2 2025.
  • In the past 5 years, Onconetix's Operating Income ranged from a high of -$1.9 million in Q2 2025 and a low of -$29.1 million during Q4 2024
  • In the last 3 years, Onconetix's Operating Income had a median value of -$6.6 million in 2023 and averaged -$9.9 million.
  • Its Operating Income has fluctuated over the past 5 years, first crashed by 28907.94% in 2024, then soared by 8578.47% in 2025.
  • Quarter analysis of 3 years shows Onconetix's Operating Income stood at -$22.0 million in 2023, then crashed by 32.19% to -$29.1 million in 2024, then surged by 92.9% to -$2.1 million in 2025.
  • Its last three reported values are -$2.1 million in Q3 2025, -$1.9 million for Q2 2025, and -$12.6 million during Q1 2025.